GQQ-792 is a non-ATP-competitive inhibitor and exhibits antitumour activity in vitro and in vivo by directly binding to PGK1 and inhibiting its kinase activity in U87-MG glioblastoma cells [87]. Here, PGK1 is linked to glioblastoma.